A recent study found that, among older adults who are generally healthy and not at high risk for type 2 diabetes, Vitamin D3 supplementation does not significantly reduce the risk of developing the disease.

AMA released its 2024 Overdose Epidemic Report and presented key findings from the past year.

Women with prepregnancy overweight or obesity may be more likely to experience postpartum depression.

The higher burden of neurological symptoms among younger and middle-aged adults translated to worse subjective quality of life, according to a recent study.

A study found that patients with obesity who were diagnosed with type 2 diabetes aged 50 or younger had the highest risk of dementia.

On the most recent episode of Over the Counter, Steve Callahan, Senior Director of Advisory & Insights at MMIT, talked with us about biosimilars and the Inflation Reduction Act.

TaQuina Warren, PharmD, owner of Focus Pharmacy in Smyrna, Delaware, discussed her career journey and why pharmacists are so crucial to the interoperability of health care.

A recent study showed that cognitive behavioral therapy could help reduce fatigue and improve concentration with moderate certainty.

Most patients with reduced opioid prescriptions during cannabis use had chronic musculoskeletal pain.

Researchers addressed vaccine effectiveness for individuals with direct household contacts that reported influenza.

Jay Holloway, PharmD, AAHIVP, Pharmacist with the AIDS Healthcare Foundation, joined Drug Topics to discuss the role pharmacists play in providing care for people with HIV.

Check out this list of our top 10 stories from November 2024.

Catch up on important nonopioid pain management news from November 2024.

Steve Callahan, Senior Director of Advisory & Insights at MMIT, discussed out-of-pocket costs and the impact biosimilars are predicted to have for patients in the future.

Jay Holloway, PharmD, AAHIVP, Pharmacist with the AIDS Healthcare Foundation, discussed the ongoing developments impacting patients with HIV and their prescription drugs.

Catch up on important COVID-19 news from November 2024.

Steve Callahan, Senior Director of Advisory & Insights at MMIT, sat down with Drug Topics to discuss industry trends behind biosimilars.

Catch up on important diabetes news from November 2024.

A recent study found that there was a significant relationship between self-efficacy for disease control and the level of glycemic control.

Researchers explored the disease activity of patients with axial spondylarthritis after various modifications to their diets.

Individuals who received tailored text message reminders about receiving a COVID-19 booster vaccine were more likely to get it.

Researchers aimed to address the associations between gout and ischemic events, specifically ischemic colitis.

Benjamin Jolley, PharmD, pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City, Utah, discussed the state of independent pharmacy.

FDA approval was granted on September 13, 2024.

Benjamin Jolley, PharmD, pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City, Utah, joined Drug Topics to discuss his career journey.